Ultrasound II: Endoscopic Ultrasound and FibroScan
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 30, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Masato Yoneda1, Emmanuel Thomas2, Yoshio Sumida3
1Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, 1500 NW 12th Avenue, Suite 1101, Miami, FL 33136, USA; Division of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
No abstract available in PubMed .